Fluorouracil: all 820 studies that test it
Page 7 of 9. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric CancerStatus unknownNCT00384878Phase 2
- Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal CarcinomaCompletedNCT00379262Phase 3
- An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic KeratosesCompletedNCT00377273Phase 4
- The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVRStatus unknownNCT00371020Phase 3
- Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)Status unknownNCT00370760Phase 3
- Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal CancerCompletedNCT00349076Phase 3
- Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin CCompletedNCT00346489Phase 4
- Docetaxel in Locally Advanced Gastric AdenocarcinomaCompletedNCT00343239Phase 2
- Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By SurgeryCompletedNCT00336960Phase 2
- Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic CancerStatus unknownNCT00323583Phase 2
- FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal CancerTerminatedNCT00323011Phase 2
- Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative PatientsCompletedNCT00309569Phase 3
- Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes CCompletedNCT00309530Phase 3
- Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic CancerTerminatedNCT00307723Phase 1/2
- Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryStatus unknownNCT00301925Phase 3
- Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal CancerCompletedNCT00296608Phase 3
- Phase I/II CT 2106 and 5-FU/FA in Colorectal CancerCompletedNCT00291785Phase 1/2
- Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment)CompletedNCT00289445Phase 1/2
- Combination Chemotherapy in Treating Young Patients With Advanced Solid TumorsCompletedNCT00281944Phase 1
- Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal CancerCompletedNCT00280176Phase 1
- Oxaliplatin and 5-FU Based Preoperative ChemoradiationCompletedNCT00278694Phase 2
- Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00275119Phase 2
- An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric CancerStatus unknownNCT00270543Phase 2
- Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable MetastasesCompletedNCT00268398Phase 3
- S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the OropharynxTerminatedNCT00268372Phase 3
- Docetaxel in Head and Neck CancerCompletedNCT00261703Phase 2/3
- Oxaliplatin in Esophagus Cancer (Advanced) 1st LineCompletedNCT00259402Phase 2
- Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic CancerCompletedNCT00251355Phase 1
- Gefitinib in Combination With Chemoradiation in Resectable Gastric CancerTerminatedNCT00237900Phase 1/2
- Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerWithdrawnNCT00233623Phase 2
- Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the PancreasCompletedNCT00220649Phase 1
- A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI TumoursCompletedNCT00220064Phase 2
- Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00215514Early Phase 1
- Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor MalignanciesCompletedNCT00215501Phase 1
- Patients Preference for Oral or i.v. TherapyCompletedNCT00212589Phase 3
- Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.CompletedNCT00209716Phase 1/2
- Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal CancerTerminatedNCT00209703Phase 2
- Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.CompletedNCT00209690Phase 1/2
- Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of EsophagusTerminatedNCT00208936Phase 2
- A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and NeckCompletedNCT00203905Phase 2
- A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal CarcinomaCompletedNCT00201396Phase 3
- A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma PatientsTerminatedNCT00201344Phase 3
- Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon CancerStatus unknownNCT00201331Phase 2
- Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary TractCompletedNCT00201305Phase 2
- Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.CompletedNCT00193882Phase 3
- Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal CancerCompletedNCT00193141Phase 2
- Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast CancerCompletedNCT00193011Phase 3
- Study of Adjuvant Radiochemotherapy for Gastric CancerCompletedNCT00188266Phase 1/2
- Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric AdenocarcinomaCompletedNCT00183911Phase 2
- Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal CarcinomaCompletedNCT00176774Phase 2
- Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or EsophagusCompletedNCT00165191Phase 2
- Very Intense Radiotherapy-chemotherapy Regimen in Advanced HNSCCCompletedNCT00162708Phase 2/3
- Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCCCompletedNCT00158652Phase 3
- Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric CancerTerminatedNCT00155883Phase 2
- A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal CancersCompletedNCT00155558Phase 1
- Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal CancerCompletedNCT00154700Phase 2
- Weekly TP-HDFL in the Treatment of Advanced TCCCompletedNCT00154687Phase 2
- Selective Dose Escalation for Esophageal CancerStatus unknownNCT00139633Phase 2
- Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139269Phase 1/2
- Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139243Phase 1/2
- Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid TumorsCompletedNCT00138177Phase 1
- Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic DeterminantsCompletedNCT00138060Phase 4
- A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast CancerCompletedNCT00124111Phase 2
- A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric CancerCompletedNCT00123318Phase 3
- The Effect of Efudex Treatment on Photoaged SkinCompletedNCT00121511Not applicable
- Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00112697Phase 2
- GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal CancerTerminatedNCT00110721Phase 2
- Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach CancerTerminatedNCT00103103Phase 2
- Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00098982Phase 1
- Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic CancerCompletedNCT00096070Phase 2
- Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal CancerStatus unknownNCT00093665Phase 2
- Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerStatus unknownNCT00091312Phase 3
- Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the ColonCompletedNCT00085163Phase 3
- Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal CancerCompletedNCT00084773Not applicable
- Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) CancerCompletedNCT00083109Phase 1/2
- Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantActive, not recruitingNCT00082706Phase 2
- Clinical Trial in Patients With Metastatic Colorectal CancerCompletedNCT00081627Phase 2
- Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid TumorsCompletedNCT00080990Phase 1
- Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00080951Phase 2
- Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the PancreasStatus unknownNCT00079365Not applicable
- Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal CancerStatus unknownNCT00075738Phase 2
- Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal CancerStatus unknownNCT00075595Phase 2
- Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00072553Phase 2
- S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the RectumWithdrawnNCT00070434Phase 2
- Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerCompletedNCT00070213Phase 3
- Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal CancerTerminatedNCT00068744Phase 2/3
- Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard ChemotherapyCompletedNCT00066846Phase 2
- Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.TerminatedNCT00065117Phase 2
- Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal CancerCompletedNCT00062426Phase 3
- A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal CancerCompletedNCT00060411Phase 1
- Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal CancerCompletedNCT00059930Phase 1
- Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic CancerCompletedNCT00059826Phase 2
- Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal CancerStatus unknownNCT00058474Phase 3
- Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00056030Phase 2
- Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid TumorsCompletedNCT00054977Phase 1
- Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric CancerCompletedNCT00054873Phase 2
- S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00054054Phase 2
- Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney CancerCompletedNCT00053820Phase 3
- Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney CancerCompletedNCT00053807Phase 3
- Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerTerminatedNCT00052585Phase 2